Cingulate Therapeutics

0 followers

‌

Cingulate® is a biopharmaceutical company utilizing its innovative Precision Timed Release™ (PTR) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products.

Industries

Headquarters

Stage

Employees

Links

Org chart

View full screen

Shane J. Schaffer

Chairman & CEO

Shane J. Schaffer

Collapse

Raul R. Silva

Chief Science Officer

Matthew Brams

Chief Medical Officer

Arthur Straughn

Co-founder Board of Directors

Jeff Bennett

Deputy General Counsel

Naama Courtemanche

Vp, Operations And Quality Assurance

Thomas Dalton

Vice President, Investor & Public Relations; Vice President, Government Affairs

Jennifer Callahan

Svp, Chief Financial Officer

Teams

View all

+12

Board of Directors

15 members

Leadership Team

3 members

CEO and Executive Team

3 members

Discover similar companies

Organon

4 followers

Syneos Health

10 followers

Eli Lilly

128 followers

Omnicell

17 followers

Alnylam Pharmaceuticals

10 followers